| 789888 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
G6PD functions as a metabolic checkpoint to regulate granzyme B expression in tumor-specific cytotoxic T lymphocytes |
2022-01-01 |
10.1136/jitc-2021-003543 |
Lu Chunwan, Yang Dafeng, Klement John D, Colson Yolonda L, Oberlies Nicholas H, Pearce Cedric J, Colby Aaron H, Grinstaff Mark W, Ding Han-Fei, Shi Huidong, Liu Kebin |
| 789887 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Live attenuated bacterium limits cancer resistance to CAR-T therapy by remodeling the tumor microenvironment |
2022-01-01 |
10.1136/jitc-2021-003760 |
Guo Fengguang, Das Jugal K, Kobayashi Koichi S, Qin Qing-Ming, A Ficht Thomas, Alaniz Robert C, Song Jianxun, Figueiredo Paul De |
| 789886 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8+ T cell and XCR1+ dendritic cell spatial co-localization |
2022-01-01 |
10.1136/jitc-2021-003571 |
Gardner Alycia, de Mingo Pulido Álvaro, Hänggi Kay, Bazargan Sarah, Onimus Alexis, Kasprzak Agnieszka, Conejo-Garcia Jose R, Rejniak Katarzyna A, Ruffell Brian |
| 789885 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
TSH-TSHR axis promotes tumor immune evasion |
2022-01-01 |
10.1136/jitc-2021-004049 |
Wu Zhenghao, Xi Zihan, Xiao Yunxiao, Zhao Xiangwang, Li Jiexiao, Feng Nan, Hu Longqing, Zheng Renjing, Zhang Ning, Wang Shuntao, Huang Tao |
| 789884 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment |
2022-01-01 |
10.1136/jitc-2021-003540 |
Gambale Elisabetta, Fancelli Sara, Caliman Enrico, Petrella Maria Cristina, Doni Laura, Pillozzi Serena, Antonuzzo Lorenzo |
| 789883 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Tumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumors |
2022-01-01 |
10.1136/jitc-2021-003091 |
Cristescu Razvan, Aurora-Garg Deepti, Albright Andrew, Xu Lei, Liu Xiao Qiao, Loboda Andrey, Lang Lixin, Jin Fan, Rubin Eric H, Snyder Alexandra, Lunceford Jared |
| 789882 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
A very long-acting IL-15: implications for the immunotherapy of cancer |
2022-01-01 |
10.1136/jitc-2021-004104 |
Hangasky John A, Chen Wei, Dubois Sigrid P, Daenthanasanmak Anusara, Müller Jürgen R, Reid Ralph, Waldmann Thomas A, Santi Daniel V |
| 789881 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Tumor mutation burden for predicting immune checkpoint blockade response: the more, the better |
2022-01-01 |
10.1136/jitc-2021-003087 |
Zheng Ming |
| 789880 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling |
2022-01-01 |
10.1136/jitc-2021-003827 |
Makino Kenichi, Long Mark D, Kajihara Ryutaro, Matsueda Satoko, Oba Takaaki, Kanehira Kazunori, Liu Song, Ito Fumito |
| 789879 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair deficient metastatic colorectal cancer |
2022-01-01 |
10.1136/jitc-2021-003312 |
Kasi Pashtoon Murtaza, Budde Griffin, Krainock Michael, Aushev Vasily N, Koyen Malashevich Allyson, Malhotra Meenakshi, Olshan Perry, Billings Paul R, Aleshin Alexey |
